BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37059391)

  • 21. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A model-based cost-effectiveness analysis.
    Diaz M; Garcia M; Vidal C; Santiago A; Gnutti G; Gómez D; Trapero-Bertran M; Fu M;
    Lung Cancer; 2021 Sep; 159():153-161. PubMed ID: 34352591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
    JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
    Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
    Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of exercise referral schemes.
    Anokye NK; Trueman P; Green C; Pavey TG; Hillsdon M; Taylor RS
    BMC Public Health; 2011 Dec; 11():954. PubMed ID: 22200193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are financial incentives cost-effective to support smoking cessation during pregnancy?
    Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
    Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario.
    Nadal E; Bautista D; Cabezón-Gutiérrez L; Ortega AL; Torres H; Carcedo D; Ruiz de Alda L; Garcia JF; Vieitez P; Rojo F
    BMC Cancer; 2021 Jun; 21(1):689. PubMed ID: 34112097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting.
    Cao P; Smith L; Mandelblatt JS; Jeon J; Taylor KL; Zhao A; Levy DT; Williams RM; Meza R; Jayasekera J
    JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35818125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
    Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
    JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness?
    Gordon LG; Hirst NG; Young RP; Brown PM
    Cost Eff Resour Alloc; 2010 Sep; 8():18. PubMed ID: 20843376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of First-Line Pembrolizumab Monotherapy Versus Chemotherapy in High Programmed Death-Ligand 1 Advanced Non-Small Cell Lung Cancer in the Irish Healthcare Setting.
    Chu RW; Vegas García A; Hickey C; Power DG; Gorry C
    Value Health; 2023 Mar; 26(3):402-410. PubMed ID: 36368626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message.
    Jones M; Smith M; Lewis S; Parrott S; Coleman T
    Addiction; 2019 Feb; 114(2):353-365. PubMed ID: 30347119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.
    Guerriero C; Cairns J; Roberts I; Rodgers A; Whittaker R; Free C
    Eur J Health Econ; 2013 Oct; 14(5):789-97. PubMed ID: 22961230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of the English smoking treatment services: evidence from practice.
    Godfrey C; Parrott S; Coleman T; Pound E
    Addiction; 2005 Apr; 100 Suppl 2():70-83. PubMed ID: 15844290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare financing systems for increasing the use of tobacco dependence treatment.
    van den Brand FA; Nagelhout GE; Reda AA; Winkens B; Evers SMAA; Kotz D; van Schayck OC
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004305. PubMed ID: 28898403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.
    Dickson R; Bagust A; Boland A; Blundell M; Davis H; Dundar Y; Hockenhull J; Martin Saborido C; Oyee J; Ramani VS
    Pharmacoeconomics; 2011 Dec; 29(12):1051-62. PubMed ID: 21967156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.